DGX
Quest Diagnostics Incorporated
Stock
$233.33+2.24 (+0.97%)Close Oct 2, 2026
- Operating cash flow, 2025
- $1.9B
- YoY, 2025
- +41.4%
- 5-year CAGR
- −1.2%
- 10-year CAGR
- +8.7%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $1.9B | +41.4% |
| 2024 | $1.3B | +4.9% |
| 2023 | $1.3B | −26.0% |
| 2022 | $1.7B | −23.1% |
| 2021 | $2.2B | +11.4% |
| 2020 | $2.0B | +61.3% |
| 2019 | $1.2B | +3.6% |
| 2018 | $1.2B | +2.1% |
| 2017 | $1.2B | +5.3% |
| 2016 | $1.1B | +35.9% |
| 2015 | $821M | −13.0% |
| 2014 | $944M | +44.8% |
| 2013 | $652M | −45.1% |
| 2012 | $1.2B | +32.6% |
| 2011 | $895M | −19.9% |
| 2010 | $1.1B | +12.1% |
| 2009 | $997M | −6.2% |
| 2008 | $1.1B | +14.7% |
| 2007 | $927M | — |